Anzeige
Mehr »
Sonntag, 08.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
452 Leser
Artikel bewerten:
(2)

Veeva Systems: Veeva Announces Clinical Study Training Application

Veeva Vault Study Training unifies learning management and clinical operations for integrated and automated training and real-time inspection readiness

BARCELONA, Spain, June 7, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Vault Study Training, a new application that brings together research sites, CROs, and sponsors into a single platform for end-to-end clinical study training. Organizations using Vault Study Training can ensure all trial staff are qualified within required timelines while automating the filing of training certificates into Veeva Vault eTMF for real-time inspection readiness.

Veeva Systems

"Veeva continues to collaborate closely with the industry to identify gaps in key processes across clinical development and deliver innovations that can improve operational efficiency," said Ed Leftin, director, information technology at Ora, Inc. "The ability to use existing data and content in Veeva Vault Clinical Suite to create training, from study start to conduct, can streamline study execution and improve compliance."

Vault Study Training builds on Veeva's experience working with more than 450 companies using Veeva Vault Clinical Suite applications and learnings from hundreds of Veeva Vault Training implementations. Life sciences companies can now address the long-standing industry challenge of training study staff and site personnel in an efficient and compliant way.

Veeva's complete and connected solution will allow life sciences companies to leverage current clinical master data and content to remove issues like redundant information, manual data entry, and siloed processes. Vault Study Training automates assignment distribution, protocol amendment management, and training certificate filing for increased efficiency and reduced end of study reconciliation.

"As studies evolve and reach new levels of complexity, companies need a streamlined and integrated training system that can scale with the demands of today's trials," said Shad Ayoub, senior director, Veeva Vault Study Training. "Veeva Vault Study Training will deliver a fundamentally better experience to sites, CROs, and sponsors."

Vault Study Training will be available to early adopters in fall 2022. To learn more about Vault Study Training, visit veeva.com/eu/VaultStudyTraining.

Additional Information
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems Follow @veeva_eu on Twitter: twitter.com/veeva_eu

About Veeva Systems

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

Veeva Forward-looking Statements

This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2022, which you can find here (a summary of risks which may impact our business can be found on pages 37 and 38), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:


Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com



Jeremy Whittaker
Veeva Systems

+49 6950955486
jeremy.whittaker@veeva.com

Logo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg

© 2022 PR Newswire
Vorsicht, geheim!
2026 startet mit einem Paukenschlag: Der DAX outperformt den US-Markt, Nachzügler holen auf. Ein erstes Signal, dass der Bullenmarkt an Breite gewinnt. Während viele Anleger weiter auf die großen Tech-Namen setzen, hat sich im Hintergrund längst ein Umschwung vollzogen. Der Fokus verschiebt sich weg von überteuerten KI-Highflyern hin zu soliden Qualitätswerten aus der zweiten Reihe.

Anleger, die jetzt clever agieren, setzen nicht auf das, was war, sondern auf das, was kommt. Unternehmen mit gesunder Bilanz, unterschätztem Potenzial und begrenztem Abwärtsrisiko könnten 2026 zu den großen Gewinnern zählen. Die Gefahr einer schärferen Korrektur bleibt real, gerade für passiv aufgestellte Investoren.

In unserem neuen Spezialreport stellen wir fünf Aktien vor, die genau jetzt das Potenzial für überdurchschnittliche Renditen bieten. Stark, günstig und bislang kaum im Fokus.

Jetzt kostenlosen Report herunterladen – bevor es andere tun!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.